Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer

H. Marshall (Sheffield, United Kingdom), A. Voskrebenzev (Hannover, Germany), A. Biancardi (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), B. Tahir (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Vogel-Claussen (Hannover, Germany)

Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Session: Evaluation of COPD and various diseases by different imaging modalities
Session type: Poster Discussion
Number: 387
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Marshall (Sheffield, United Kingdom), A. Voskrebenzev (Hannover, Germany), A. Biancardi (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), B. Tahir (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Vogel-Claussen (Hannover, Germany). Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer. 387

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Year: 2019



Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations
Source: Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017
Year: 2017



Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017



1H and 129Xe MRI to detect functional and structural lung disease in sub-clinical cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009



Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006


Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout
Source: Eur Respir J, 52 (5) 1800821; 10.1183/13993003.00821-2018
Year: 2018



Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010

Indacaterol/glycopyrronium increases lung ventilation in COPD patients as measured by hyperpolarized 3He MRI
Source: International Congress 2018 – COPD management
Year: 2018


Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016
Year: 2017



Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019



Hyperpolarised 129-xenon diffusion-weighted MRI in interstitial lung disease
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019


Regional hyperpolarised 129-xenon diffusion-weighted MRI in patients with IPF
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020




Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI)
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017

Proton MRI assessment of lung structure and function in people with cystic fibrosis
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021